Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States
Conclusion
In the GT1 HCV population coinfected with HIV, 3D ± R was cost-effective compared to NT, SOF + R, and SOF + PR. In the treatment-naïve sub-population, 3D ± R was cost-effective compared to NT and SOF/LDV.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Drugs & Pharmacology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Norvir | Study | Urology & Nephrology